Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies-a retrospective single-centre analysis of 200 cases.

"Declarations Ethics approvalThis retrospective chart review study was approved by the Ethics Committee of the Medical Faculty of the Otto-von-Guericke University Magdeburg, Magdeburg, Germany (approval no. 92/18). Patient consentGiven the nature of a retrospective chart review study and using routine clinical data, written informed consent was not required within the study. Permission to reproduce material from other sourcesNot applicable. Clinical trial registrationThis retrospective chart review study was not registered within a clinical trial registry. Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

"Funding Open Access funding enabled and organized by Projekt DEAL. The authors received no financial support for the research, authorship, and/or publication of this article."

"Clinical trial registration: This retrospective chart review study was not registered within a clinical trial registry."